PAS
CCCC icon

Point72 Asia (Singapore)’s C4 Therapeutics CCCC Stock Holding History

Point72 Asia (Singapore)’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$48.2K Sell
21,708
-21,739
-50% -$52.2K 0.01% 572
2025
Q2 		$62.1K Buy
43,447
+43,446
+4,344,600% +$63.2K 0.01% 553
2025
Q1 		$2 Buy
+1
New +$3 ﹤0.01% 830
2024
Q1 		– Sell
-3,928
Closed -$22.2K – 1072
2023
Q4 		$22.2K Buy
+3,928
New +$8.96K 0.01% 444

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asia (Singapore)'s CCCC Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its C4 Therapeutics (CCCC) stake by 50% in Q3 2025, selling an estimated $52.2K and leaving 21,708 shares worth $48.2K. The position accounts for 0.01% of the portfolio, ranked #572.

Point72 Asia (Singapore) first reported a position in CCCC in Q4 2023 and has held it in 4 quarters since. The position peaked at $62.1K in Q2 2025. 97 funds tracked by Wall St. Rank hold CCCC as of Q3 2025.

  • Point72 Asia (Singapore) held 21,708 shares of C4 Therapeutics worth $48.2K as of Q3 2025.
  • Point72 Asia (Singapore) sold 21,739 C4 Therapeutics shares in Q3 2025, an estimated $52.2K.
  • C4 Therapeutics made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #572 holding.
  • Point72 Asia (Singapore) first reported a position in C4 Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Point72 Asia (Singapore)'s C4 Therapeutics position peaked at $62.1K in Q2 2025.
  • 97 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.